Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression

Kidney International

Volumn 65, Issue 6, 2004, Pages 2071-2080

  Höcherl, Klaus ^a   Kees, Frieder ^a   Krämer, Bernhard K ^a   Kurtz, Armin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cyclooxygenase; Kidney; Renin

Indexed keywords

CYCLOOXYGENASE 2; CYCLOSPORIN A; FUROSEMIDE; LOOP DIURETIC AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; ROFECOXIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURETIC ACTIVITY; DRUG POTENTIATION; ENZYME INHIBITION; MALE; NATRIURESIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION;

EID: 2442703936     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00627.x     Document Type: Article

References (46)

1. SHANKAR SS, BRATER DC: Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 284:F11-F21, 2003
2. 2. Am J Physiol 247:F555-F561, 1984
3. BRATER DC, BECK JM, ADAMS BV, CAMPBELL WB: Effects of indomethacin on furosemide-stimulated urinary PGE2 excretion in man. Eur J Pharmacol 65:213-219, 1980
4. MANN B, HARTNER A, JENSEN BL, et al: Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int 59:62-68, 2001
5. KAMMERL MC, NUSING RM, SCHWEDA F, et al: Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2. Clin Pharmacol Ther 70:468-474, 2001
6. KAMMERL MC, NUSING RM, RICHTHAMMER W, et al: Inhibition of COX-2 counteracts the effects of diuretics in rats. Kidney Int 60:1684-1691, 2001
7. REINALTER SC, JECK N, BROCHHAUSEN C, et al: Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 62:253-260, 2002
8. NUSING RM, REINALTER SC, PETERS M, et al: Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: Therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. Clin Pharmacol Ther 70:384-390, 2001
9. KOMHOFF M, JECK ND, SEYBERTH HW, et al: Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome. Kidney Int 58:2420-2424, 2000
10. CHENG HF, WANG JL, ZHANG MZ, et al: Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest 103:953-961, 1999
11. HARDING P, CARRETERO OA, BEIERWALTES WH: Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics. J Hypertens 18:1107-1113, 2000
12. HARTNER A, CORDASIC N, GOPPELT-STRUEBE M, et al: Role of macula densa cyclooxygenase-2 in renovascular hypertension. Am J Physiol Renal Physiol 284:F498-F502, 2003
13. HÖCHERL K, KAMMERL MC, SCHUMACHER K, et al: Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake. Am J Physiol Renal Physiol 283:F294-F301, 2002
14. RODRIGUEZ F, LLINAS MT, GONZALEZ JD, et al: Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake. Hypertension 36:276-281, 2000
15. ROSSAT J, MAILLARD M, NUSSBERGER J, et al: Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 66:76-84, 1999
16. HÖCHERL K, DREHER F, VITZTHUM H, et al: Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney. J Am Soc Nephrol 13:2427-2436, 2002
17. JENSEN BL, KURTZ A: Differential regulation of renal cyclooxygenase mRNA by dietary salt intake. Kidney Int 52:1242-1249, 1997
18. HÖCHERL K, WOLF K, CASTROP H, et al: Renocortical expression of renin and of cyclooxygenase-2 in response to angiotensin II AT1 receptor blockade is closely coordinated but not causally linked. Pflugers Arch 442:821-827, 2001
19. CHAUDHARY RS, GANGWAL SS, JINDAL KC, KHANNA S: Reversedphase high-performance liquid chromatography of ketorolac and its application to bioequivalence studies in human serum. J Chromatography 614:180-184, 1993
20. KASKEL FJ, DEVARAJAN P, ARBEIT LA, et al: Cyclosporine nephrotoxicity: Sodium excretion, autoregulation, and angiotensin II. Am J Physiol 252:F733-F742, 1987
21. SIEGL H, RYFFEL B, PETRIC R, et al: Cyclosporine, the renin-angiotensin-aldosterone system, and renal adverse reactions. Transplant Proc 15 (Suppl 1): 2719-2725, 1983
22. ZHANG W, VICTOR RG: Calcineurin inhibitors cause renal afferent activation in rats: A novel mechanism of cyclosporine-induced hypertension. Am J Hypertens 13:999-1004, 2000
23. GROBECKER HF, RIEBEL K, WELLENHOFER T: Cyclosporine A-induced hypertension in SHR and WKY: Role of the sympathoadrenal system. Clin Exp Pharmacol Physiol 22 (Suppl 1):S94-S95, 1995
24. CASTROP H, VITZTHUM H, SCHUMACHER K, et al: Low tonicity mediates a downregulation of cyclooxygenase-1 expression by furosemide in the rat renal papilla. J Am Soc Nephrol 13:1136-1144, 2002
25. HÖCHERL K, ENDEMANN D, KAMMERL MC, et al: Cyclo-oxygenase-2 inhibition increases blood pressure in rats. Br J Pharmacol 136:1117-1126, 2002
26. GRETZER B, MARICIC N, RESPONDEK M, et al: Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol 132:1565-1573, 2001
27. SHIHAB FS, BENNETT WM, TANNER AM, ANDOH TF: Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int 52:660-673, 1997
28. RODRIGUEZ F, LLINAS MT, GONZALEZ JD, et al: Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake. Hypertension 36:276-281, 2000
29. 2 inhibits AVP-induced water flow in cortical collecting ducts by protein kinase C activation. Am J Physiol 259:318-325, 1990
30. SAKAIRI Y, JACOBSON HR, NOLAND TD, BREYER MD: Luminal prostaglandin E receptors regulate salt and water transport in rabbit cortical collecting duct. Am J Physiol 269:257-265, 1995
31. 2 on chloride transport across the rabbit thick ascending limb of Henle. J Clin Invest 64:495-502, 1979
32. 2 inhibits sodium transport in the rabbit CCD by protein kinase C activation. J Clin Invest 87:1992-1998, 1991
33. KAOJARERN S, CHENNAVASIN P, ANDERSON S, BRATER DC: Nephron site of effect of nonsteroidal anti-inflammatory drugs on solute excretion in humans. Am J Physiol 244:F134-F139, 1983
34. FERNANDEZ-LLAMA P, ECELBARGER CA, WARE JA, et al: Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop. Am J Physiol 277:F219-F226, 1999
35. LASSILA M, FINCKENBERG P, PERE AK, et al: Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. Br J Pharmacol 130:1339-1347, 2000
36. ITO S, CARRATERO OA, ABE K, et al: Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa. Kidney Int 35:1138-1144, 1989
37. JENSEN BL, SCHMID C, KURTZ A: Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtglomerular cells. Am J Physiol 271:659-669, 1996
38. SUZUKI S, FRANCO-SAENZ R, TAN SY, MULROW PJ: Effects of indomethacin on plasma renin activity in the conscious rat. Am J Physiol 240:E286-E289, 1981
39. LUNDERGAN CF, FITZPATRICK TM, ROSE JC, et al: Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide. Pharmacology 246:102-106, 1988
40. PICKKERS P, DORMANS TP, RUSSEL FG, et al: Direct vascular effects of furosemide in humans. Circulation 96:1847-1852, 1997
41. LIGUORI A, CASINI A, DI LORETO M, et al: Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure. Eur J Clin Pharmacol 55:117-124, 1999
42. HÖCHERL K, DREHER F, KURTZ A, BUCHER M: Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure. Hypertension 40:947-953, 2002
43. ORIJI GK: Cyclosporine A-induced prostacyclin release is maintained by extracellular calcium in rat aortic endothelial cells: Role of protein kinase C. Prostaglandins Leukot Essent Fatty Acids 61:119-123, 1999
44. FITZGERALD GA, HOSSMANN V, HUMMERICH W, KONRADS A: The renin-kallikrein-prostaglandin system: Plasma active and inactive renin and urinary kallikrein during prostacyclin infusion in man. Prostaglandins Med 5:445-456, 1980
45. 2) in experimental hypertension and its influence on plasma renin activity in rats. Prostaglandins Med 1:359-372, 1978
46. NAMBA T, OIDA H, SUGIMOTO Y, et al: cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla. J Biol Chem 269:9986-9992, 1994